Functional genomics to new drug targets
- 1 November 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 3 (11) , 965-972
- https://doi.org/10.1038/nrd1552
Abstract
The completion of the sequencing of the human genome, and those of other organisms, is expected to lead to many potential new drug targets in various diseases, and it is predicted that novel therapeutic agents will be developed against such targets. The role of functional genomics in modern drug discovery is to prioritize these targets and to translate that knowledge into rational and reliable drug discovery. Here, we describe the field of functional genomics and review approaches that have been applied to drug discovery, including RNA profiling, proteomics, antisense and RNA interference, model organisms and high-throughput, genome-wide overexpression or knockdowns, and outline the future directions that are likely to yield new drug targets from genomics.Keywords
This publication has 74 references indexed in Scilit:
- Identification of common molecular subsequencesPublished by Elsevier ,2004
- Expression and Characterization of a 5-oxo-6E,8Z,11Z,14Z-Eicosatetraenoic Acid Receptor Highly Expressed on Human Eosinophils and NeutrophilsMolecular Pharmacology, 2003
- Yellow pages to the transcriptomePharmacogenomics, 2002
- The Sequence of the Human GenomeScience, 2001
- What is the value added by human intervention in protein structure prediction?Proteins-Structure Function and Bioinformatics, 2001
- Distinctive gene expression patterns in human mammary epithelial cells and breast cancersProceedings of the National Academy of Sciences, 1999
- A Genomic Perspective on Protein FamiliesScience, 1997
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997
- Basic local alignment search toolJournal of Molecular Biology, 1990
- [5] Rapid and sensitive sequence comparison with FASTP and FASTAPublished by Elsevier ,1990